What is Blue Water Vaccines, Inc. (BWV) stock price today?

Blue Water Vaccines, Inc. (BWV) is currently trading at $0.18, down 6.97% today.

What is BWV P/E ratio?

Blue Water Vaccines, Inc.'s P/E ratio is -0.09. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is BWV return on equity (ROE)?

Blue Water Vaccines, Inc.'s return on equity (ROE) is -105.46%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Blue Water Vaccines, Inc.'s market cap?

Blue Water Vaccines, Inc. has a market capitalization of $3.41M.

NASDAQ · Biotechnology

Blue Water Vaccines, Inc. (BWV) Stock

$0.18 -6.97% NASDAQ: BWV Healthcare

Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to the worldwide discovery and development of vaccines aimed at preventing infectious diseases.

Valuation

Metric	Value
Price	$0.18
Market Cap	$3.41M
P/E Ratio	-0.09
P/B Ratio	0.04
P/S Ratio	0.38
EPS (TTM)	$-16.56
52-Week High	$1.95
52-Week Low	$0.16
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-105.46%
ROA	-65.41%
ROCE	-57.65%
Gross Margin	79.63%
Operating Margin	-922.72%
Net Margin	-1400.00%
Debt/Equity	0.02
Current Ratio	1.41

Annual Financials (USD)

Metric	2020	2021	2022	2024	2025
Revenue	$0	$0	$0	$3.0M	$1.0M
Operating Profit	$-2.0M	$-3.0M	$-13.0M	$-56.0M	$-18.0M
Net Profit	$-2.0M	$-3.0M	$-13.0M	$-59.0M	$-14.0M
EPS	$-0.14	$-0.31	$-1.08	$-21.45	$-16.56
Op Margin	—	—	—	-2238.0%	-2190.0%

Balance Sheet (USD)

Metric	2020	2021	2022	2024	2025
Total Assets	$5.0M	$3.0M	$26.0M	$28.0M	$25.0M
Total Liabilities	$0	$2.0M	$4.0M	$19.0M	$9.0M
Cash	$4.0M	$2.0M	$26.0M	$1.0M	$5.0M
Borrowings	$0	$0	$0	$9.0M	$0

Cash Flow (USD)

Metric	2020	2021	2022	2024	2025
Operating Cash Flow	$-2.0M	$-2.0M	$-9.0M	$-10.0M	$-10.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$32.0M	$8.0M	$15.0M
Net Cash Flow	$-2.0M	$-2.0M	$24.0M	$-4.0M	$5.0M
Free Cash Flow	$-2.0M	$-2.0M	$-9.0M	$-11.0M	$-10.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.34
FCF Yield	-3523.40%
Quick Ratio	1.37
Interest Coverage	-12.81
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AFMDAffimed N.V.	$0.18	+0.00%	-0.02	$2.98M	0.00%
AZRXAzurRx BioPharma, Inc.	$3.45	+2.07%	-0.73	$3.43M	0.00%
BCELAtreca, Inc.	$0.09	-1.32%	-0.04	$3.57M	0.00%
GRTSGritstone bio, Inc.	$0.03	-31.78%	-0.03	$3.80M	0.00%
IDRAIdera Pharmaceuticals, Inc.	$0.43	-21.82%	-0.06	$0	0.00%

About Blue Water Vaccines, Inc.

Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to the worldwide discovery and development of vaccines aimed at preventing infectious diseases. Currently in preclinical stages, their most prominent vaccine candidates are BWV-101, an influenza shot, and BWV-102, designed to counter H1 pre-pandemic threats. The company's developmental portfolio also includes other preclinical programs such as BWV-201, a vaccine addressing acute otitis media caused by Streptococcus pneumoniae; BWV-301, a combined vaccine for norovirus and rotavirus; and BWV-302, a dual-target vaccine for norovirus and malaria. Founded in 2018, BWV's operations are based in Cincinnati, Ohio.

Blue Water Vaccines, Inc. is headquartered in US.

Blue Water Vaccines, Inc. (BWV) stock trades at $0.18 with a market capitalization of $3.41M. The stock is valued at a price-to-earnings (P/E) ratio of -0.09, price-to-book of 0.04, price-to-sales of 0.38. Over the past 52 weeks the stock has ranged between $0.16 and $1.95, and currently trades 90.8% below its 52-week high.

On profitability, Blue Water Vaccines, Inc. generates a return on equity (ROE) of -105.46%, return on capital employed of -57.65%, an operating margin of -922.72%, a net profit margin of -1400.00%.

Official website: www.bluewatervaccines.com